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Abstract
Background Standards for residual tumour measurement
after resection of gliomas with no or minimal enhancement
have not yet been established. In this study residual
volumes on early and late postoperative T2-/FLAIR-
weighted MRI are compared.
Methods A retrospective cohort included 58 consecutive
glioma patients with no or minimal preoperative gadolinium
enhancement. Inclusion criteria were first-time resection
between 2007 and 2009 with a T2-/FLAIR-based target
volume and availabilityof preoperative, early (<48 h)and late
(1–7 months) postoperative MRI. The volumes of non-
enhancing T2/FLAIR tissue and diffusion restriction areas
were measured.
Results Residual tumour volumes were 22% smaller on late
postoperative compared with early postoperative T2-
weighted MRI and 49% smaller for FLAIR-weighted
imaging. Postoperative restricted diffusion volume correlated
with the difference between early and late postoperative
FLAIR volumes and with the difference between T2 and
FLAIR volumes on early postoperative MRI.
Conclusion We observed a systematic and substantial over-
estimation of residual non-enhancing volume on MRI within
48 h of resection compared with months postoperatively, in
particular for FLAIR imaging. Resection-induced ischaemia
contributes to this overestimation, as may other operative
effects. This indicates that early postoperative MRI is less
reliable to determine the extent of non-enhancing residual
glioma and restricted diffusion volumes are imperative.
Keywords Glioma.Brain.Neurosurgical procedures.
Magnetic resonance imaging.Diagnostic techniques and
procedures.Diffusion magnetic resonance imaging
Introduction
Initial treatment for gliomas usually consists of resective
surgery in order to obtain a histopathological diagnosis and
to accomplish as radical a glioma removal as possible with
preservation of brain functions. Important determinants of
survival in gliomas are histopathological grading, patient
age and clinical condition before treatment [1, 2]. Residual
tumour after resection is an independent prognostic factor
for survival of low-grade and high-grade gliomas [3–6].
Therefore, a reliable quantitative measure of residual
tumour after resection is important to accurately evaluate
the impact of surgery on the course of the disease and to
compare the extent of resection between patient series [6, 7].
For high-grade gliomas residual tumour is usually
determined by tumour volume calculation on MRI of the
elements that enhance after administration of gadolinium on
T1-weighted imaging. To avoid artefacts from enhancing
gliotic tissue in the resection margins and from adjuvant
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tumour, the postoperative MRI is performed within 48 h of
surgery [8]. Gliomas may also present with no or minimal
gadolinium enhancement on MRI. A lower grade glioma is
then suspected and the target volume for resection is
concordantly based on the non-enhancing elements that
are hyperintense on T2-weighted sequences. FLAIR-
weighted sequences have been particularly useful for this
purpose, because the contrast between tumour and normal
brain is superior to T2-weighted sequences as the signal
from cerebrospinal fluid is suppressed [9]. Standards for the
timing of postoperative MRI of gliomas with no or minimal
enhancement have however not been established. The effects
of the timing of postoperative MRI and of the pulse-sequence
on residual tumour measurements have not been determined.
We hypothesised that resection-induced ischaemia might
contribute to differences in residual tumour volumes.
This study aimed to compare residual tumour volumes
measured on early versus late postoperative T2- and FLAIR-
weighted MRI after resection of gliomas that show no or
minimal gadolinium enhancement on preoperative imaging.
Materials and methods
Inclusion criteria
All adult patients with a histopathological diagnosis of a
glioma grade 1 to 4 according to the WHO 2007 criteria
[10], who had surgery between January 2007 and December
2009 were retrieved from a consecutive patient series in an
electronic database of our institution, which is a tertiary
referral centre for brain tumour treatment. Then, patients
with first-time resective surgery were selected for analysis,
excluding stereotactic or open biopsies. In order to ensure
that the target volume for resection was based on T2-/
FLAIR-weighted imaging, only gliomas with no or minimal
gadolinium enhancement on preoperative T1-weighted
imaging were selected. However, focal or faint enhancement
arbitrarily up to 15% of the T2/FLAIR volume, as determined
volumetrically, was allowed. Furthermore, MR imaging was
required to be available (a) preoperatively, (b) within 48 h of
surgery, i.e. early postoperatively, and (c) between 2 and
6 months after surgery, i.e. late postoperatively.
The local ethical committee approved the research
protocol and waived informed consent of participants.
Resective surgery
The patients in this study were preoperatively considered to
have either a low-grade glioma or an anaplastic focus in a
previously low-grade glioma. Therefore, the target volume
for resection consisted of the T2/FLAIR volume. To
minimise the risk of neurological morbidity this target
volume was restricted by eloquent brain areas as deter-
mined by intraoperative cortical and subcortical electro-
stimulation mapping. The relation between the tumour and
eloquent areas was determined according to the definitions
used in the prognostic classification system of Chang et al
[2]. Preoperative functional MRI, magnetic source imaging
and diffusion tensor imaging tractography were obtained, as
required by the location of the tumour. In general, the
resection proceeded until eloquent brain areas were reached
or volumetric tumour resection was complete. The tumour
was subpially resected along sulci and fissures to minimise
ischaemia around the resection cavity.
MRI data acquisition
MR imaging was performed on a 1.5T system (Siemens
Sonata or Avanto; Siemens Medical Systems, Erlangen,
Germany). The imaging protocol included non-enhanced
axial T1-weighted spin echo images [repetition time/echo
time (TR/TE) 520-600/8-12 ms] with 5-mm section
thickness and axial T2-weighted turbo spin echo images
(TR/TE 5190-8670/93-101 ms) with 5-mm section thick-
ness. Sagittal 3D turbo fluid-attenuated inversion-recovery
(tFLAIR) images [repetition time/echo time/inversion time
(TR/TE/TI) 6500/355/2200 ms] with 1.3-mm section
thickness plus axial multiplanar reconstructions (MPR)
and axial single shot spin echo echo-planar diffusion-
weighted (DWI) images (TR/TE 3400/122 ms) with 5-mm
section thickness were added to the imaging protocol in
2009. Diffusion gradients were applied along 3 orthogonal
directions using b-values of 0, 500 and 1000 s/ mm
2.
Apparent diffusion coefficient (ADC) maps were calculated
from the DWI images. Post-contrast (0.2 mmol/Kg) sagittal
3D T1-weighted gradient-echo (MPRAGE) images (TR/
TE/TI 2300-2700/5-4.5/950 ms) with 1- to 1.5-mm section
thickness and axial T1-weighted spin echo images with5-mm
section thickness were obtained. In all patients preoperative
imagingwasrepeatedatourinstitutionfornavigationprotocol
purposes, even if preoperative imaging was available from a
referring hospital.
MRI volumetry
Tumour volumes were measured using image fusion and
volumetric software (BrainLab iPlan Cranial 2.6; BrainLab
AG, Feldkirchen, Germany). MRI volumetry was based on
the Cavalieri principle which provides unbiased volume
estimates [11]. For this purpose tumour contours were
manually segmented on sequential axial images and
verified in the coronal and sagittal reconstruction planes.
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was multiplied by slice thickness to obtain the estimated
volume in cm
3. This method has been demonstrated to be
reproducible and accurate [12, 13]. In this way preoper-
ative tumour volumes were determined for T2-, FLAIR-
and gadolinium-enhanced T1-weighted images. The resid-
ual tumour after resection was also determined on T2- and
FLAIR-weighted sequences for early and late postopera-
tive imaging. The postoperative ischaemic volume was
measured on an early postoperative diffusion-weighted
sequence. Tumour and ischaemia were manually segment-
ed independently by two observers (SB, PW) and
disagreement was resolved by consensus with a third
observer (ES).
Comparison of volume measurements
Several volume measurements were compared. To deter-
mine the effect of MRI timing on tumour volume measure-
ments, early and late postoperative volumes were compared
for T2- and FLAIR-weighted MRI. To determine the effect
of pulse-sequence on tumour volume assessment, T2 and
FLAIR volumes were compared on preoperative, early and
late postoperative MRI. To determine the effect of resection-
induced ischaemia ondifferencesinresidualtumourvolumes,
tissuevolumes withrestricteddiffusiononearlypostoperative
MRI were compared with the difference between early and
late postoperative volumes for T2- and FLAIR-weighted
imaging.
Statistical analysis
Tumour volumes for individual patients were plotted for
visual inspection. In the case of perfect agreement between
two volumes, a linear regression coefficient of 1.0 with an
intercept of 0 was expected (plotted as a dashed line) with a
correlationcoefficientof1.0.Theactualregressioncoefficients
with 95% confidence intervals were calculated by linear
regression analysis with a fixed intercept of 0. As the volumes
were considered not to be normally distributed, Spearman’s
correlation coefficient was calculated. Bland-Altman plots
werecreatedtovisualiseagreementbetweenvolumeestimates.
Absolute volume differences were compared using the
Wilcoxon signed rank test for paired samples.
Results
Patient and MRI characteristics and histopathology
The study population was a subset of 58 patients out of 223
with a glioma diagnosis in the inclusion time interval.
Table 1 lists the details of the study population, consisting
of 25 women and 33 men with a mean age of 44.7 years
(range 20 to 70).
Preoperative MRI was performed at a median of 23 days
(range: 1 to 282) before resection which showed no T1
gadolinium enhancement in 32 and minimal enhancement
in 26 patients. The median preoperative T2 and FLAIR
tumour volumes were 80.7 cm
3 (range: 0.8 to 288.2) and
77.9 cm
3 (range: 1.3 to 344.5), respectively. Histopatho-
logical diagnosis established WHO grade 1 in 2 patients
(3%), grade 2 in 35 (60%), grade 3 in 14 (24%) and grade 4
in 7 (12%). Histopathological subtypes included 2 pilocytic
astrocytomas (WHO grade 1); 14 astrocytomas, 18 oligo-
dendrogliomas and 3 oligoastrocytomas (WHO grade 2); 6
anaplastic astrocytomas, 5 anaplastic oligodendrogliomas, 3
anaplastic oligoastrocytomas (WHO grade 3) and 7
glioblastomas (WHO grade 4).
Early and late postoperative T2 images were available
for 52 patients; early and late postoperative FLAIR images
for 14 patients. Early postoperative T2 and FLAIR images
were available for 23 patients; late postoperative T2 and
FLAIR images for 24 patients. Early postoperative
diffusion-weighted images were available for 33 patients.
Early postoperative MRI was obtained within 48 hours of
resection in all patients, 44 on the first postoperative day,
14 on the second day. Late postoperative MRI was
performed at a median of 100 days (range: 34 to 192) after
resection; 18 within 3 months postoperatively, 31 between
four and 6 months and 7 between seven and 9 months.
Residual tumour volumes on early compared
with late postoperative MRI
The median early and late T2 residual volumes were
28.7 cm
3 a n d2 2 . 4c m
3, respectively, resulting in a 22%
smaller residual volume on late T2 images. Residual T2
tumour volumes on early postoperative MRI demonstrated
a systematically larger residual tumour volume (on
average 4.3 cm
3)c o m p a r e dw i t hl a t ep o s t o p e r a t i v eM R I
(Fig. 1a, c) with a regression coefficient of 0.767 (95%CI:
0.665–0.870), a correlation coefficient of 0.81 (p<0.0001)
and a paired Wilcoxon rank sum of V=746.5 (p=0.295).
Similarly, the median early and late FLAIR residual
volumes were 27.3 cm
3 and 13.9 cm
3, respectively,
resulting in a 49% smaller residual volume on late FLAIR
images. Systematically larger residual FLAIR tumour
volumes (on average 5.7 cm
3) were observed based on
early postoperative MRI compared with late postoperative
MRI (Fig. 1b, d) with a regression coefficient of 0.833
(95%CI: 0.693–0.973), a correlation coefficient of 0.95
(p<0.0001) and a paired Wilcoxon rank sum of V=78(p=
0.119). Data plots confirmed that the differential residual
1528 Eur Radiol (2011) 21:1526–1534tumour volumes were independent of glioma grading,
subtyping and timing of late postoperative MRI.
Tumour volumes on FLAIR- compared
with T2-weighted imaging
FLAIR tumour volumes were marginally larger (on average
4.7 cm
3) compared with T2 volumes on preoperative MRI
(Fig. 2a, d) with a regression coefficient of 1.068 (95%CI:
1.033–1.102), a correlation coefficient of 0.98 (p<0.0001)
and a paired Wilcoxon rank sum of V=419.5 (p=0.056).
FLAIR residual tumour volumes were substantially larger
(on average 7.2 cm
3) than T2 tumour volumes on early
postoperative MRI (Fig. 2b, e) with a regression coefficient
of 1.156 (95%CI: 1.049–1.262), a correlation coefficient of
0.96 (p<0.0001) and a paired Wilcoxon rank sum of V=40
(p=0.009). On the late postoperative MRI, FLAIR and T2
residual tumour volumes were comparable (Fig. 2c, f): T2
tumour volumes on average 1.5 cm
3 larger with a regression
coefficient of 0.948 (95%CI: 0.880–1.015), a correlation
coefficient of 0.94 (p<0.0001) and a paired Wilcoxon rank
sum of V=194 (p=0.218). Again, data plots confirmed that
the differential residual tumour volumes were independent of
glioma grading and timing of late postoperative MRI.
Postoperative ischaemia
The median restricted diffusion volume was 6.1 cm
3. The
restricted diffusion volume only weakly correlated with the
difference between early and late postoperative volumes on
T2-weighted imaging (Fig. 3a) with a correlation coeffi-
cient of 0.32 (p=0.089). The restricted diffusion volume
however did correlate more strongly with the difference
between early and late postoperative volumes on FLAIR-
weighted imaging (Fig. 3b) with a regression coefficient of
0.877 (95%CI: 0.486–1.267) and a correlation coefficient
of 0.76 (p=0.004). In addition, the restricted diffusion
volume also correlated with the difference between FLAIR
and T2 volumes on early postoperative MRI (Fig. 3c) with
a regression coefficient of 0.655 (95%CI: 0.440–0.871) and
a correlation coefficient of 0.77 (p=0.0001).
Discussion
This study population consisted of a consecutive series of
patients in whom resective surgery targeted a FLAIR-based
tumour volume. Owing to the absence of overt T1
gadolinium enhancement these lesions were deemed low-
WHO1 WHO2 WHO3 WHO4 total
n (%) 2 (3%) 35 (60%) 14 (24%) 7 (12%) 58
patient demographics
age, mean (SE) 36.0 (0.4) 45.4 (1.7) 45.2 (3.7) 42.8 (7.0) 44.7 (1.6)
female/male 0/2 18/17 5/9 1/6 25/33
No. pts with radiotherapy 0 2 6 2 10
No, pts with chemo-irradiation 0 0 2 5 7
tumour lateralisation and location
L/R 0/2 15/20 5/9 3/4 23/35
nr pts with eloquent
tumour location
22 6 7 64 1
frontal 0 8 7 1 16
SMA 0 7 2 2 11
parietal 0 6 3 2 11
temporal 0 2 1 1 4
insula 2 12 1 1 16
MRI characteristics
preoperative T2 hyperintense
tumour volume in cm
3,
mean (SE)
135.0 (58.2) 71.6 (8.7) 129.1 (19.8) 76.6 (12.2) 88.3 (8.0)
preoperative FLAIR
hyperintense tumour volume
in cm
3, mean (SE)
129.9 (52.0) 72.3 (9.9) 138.7 (29.9) 89.8 (16.2) 90.3 (9.7)
days preoperative MRI,
mean (SE)
162 (121) 56 (15) 27 (9) 38 (14) 50 (10)
days early postoperative MRI,
mean (SE)
1 (0) 1.4 (0.1) 1.8 (0.3) 1.6 (0.4) 1.5 (0.1)
days late postoperative MRI,
mean (SE)
189 (10) 104 (7) 117 (21) 96 (15) 109 (7)
Table 1 Patient demographics
and MRI characteristics
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histopathological diagnosis however established that 21
(36%) of the gliomas were in fact of high grade (WHO
grade 3 or 4), reflecting the well-known discordance
between MRI and histopathological grading of glioma
[14–16]. Three main observations were made in this study.
First, a systematic and substantial overestimation of
residual tumour on MRI within 48 h of resection, indicating
that late MRI months after surgery is more suitable to
determine the extent of resection than an early MRI days
after resection. Second, our data do not support a preference
for either FLAIR- or T2-weighted imaging for either pre- or
late postoperative imaging, although FLAIR-weighted
imaging is more sensitive for early postoperative overesti-
mation than T2-weighted imaging. Third, resection-induced
diffusion restriction contributes to the residual volume
overestimation of early compared with late postoperative
MRI. These main findings are illustrated with a patient
example in Fig. 4.
Several factors likely contribute to the reduction of T2/
FLAIR hyperintense regions between early and late
postoperative MRI. It is unlikely that residual tumour
actually regresses in the months following resection,
although in theory involution of tumoural tissue induced
by hypoperfusion due to surgical devascularisation can be
postulated. The contribution of oedema and contusion of
brain tissue surrounding the resection cavity, which sub-
sides in weeks to months after resection, seems to be a
more likely explanation. This reversible oedema can be
either due to tumour compression that was present before
resection, similar to peritumoral oedema as observed in
some meningiomas for instance, or due to surgical
manipulation of the tissue surrounding the resection
cavity. Furthermore, the diffusion restricted areas may
evolve in ischaemic (non-tumoral) tissue with volume
involution over weeks to months similar to spontaneous
infarction [17].
It is not surprising that T2 and FLAIR sequences provide
similar tumour volumes on preoperative and late postopera-
tive MRI because these sequences essentially measure the
same physical properties of tissue except for the suppression
of cerebrospinal fluid signal in the FLAIR sequence. This
Fig. 1 Residual tumour volumes
in mL comparing early and late
postoperative MRI based on T2-
weighted imaging and FLAIR-
weighted imaging shown as data
plots (a and b) and Bland-
Altman plots (c and d) respec-
tively depicting systematic over-
estimation of residual tumour
volume by early postoperative
MRI. Each data point represents
measurements obtained from one
patient, tagged by glioma grade
according to the legend. The
straight diagonal line in a and b
represents hypothetical perfect
agreement and the dotted lines
the actual linear regression fit
and corresponding 95% confi-
dence interval. The three dotted
horizontal lines in c and d
represent the average differential
volume and corresponding 95%
confidence interval
1530 Eur Radiol (2011) 21:1526–1534suppression provides superior contrast among tumour, cere-
brospinal fluid and brain, thereby facilitating for instance
segmentation algorithms to delineate tumour volume in
neuronavigation preplanning [18–20]. Nevertheless, FLAIR
tumour volumes tend to be larger than T2 volumes on early
postoperative MRI. This could be explained by differences in
sensitivity in detecting ischaemia especially in grey matter
[21–24] rather than by differences in the detection of residual
Fig. 3 Plots of diffusion restriction volume on early postoperative
MRI and (a) the difference in T2 residual tumour volumes of early and
late postoperative MRI, (b) the difference in FLAIR residual tumour
volumes of early and late postoperative MRI and (c) the difference in
early postoperative MRI residual tumour volumes of T2- and FLAIR-
weighted imaging. Data points, tagging and line styles as in Fig. 1
Fig. 2 Residual tumour volumes in mL comparing T2- and FLAIR-
weightedimagingrespectivelybasedonpreoperative,earlypostoperative
and late postoperative MRI shown as data plots (a, b and c) and Bland
Altman plots (d, e and f) depicting good agreement in residual tumour
volume based on preoperative and late postoperative MRI and
systematic overestimation of FLAIR-weighted imaging on early
postoperative MRI. Data points, tagging and line styles as in Fig. 1
Eur Radiol (2011) 21:1526–1534 1531tumour or oedema originating from tumour compression or
surgical manipulation.
Recent studies on the extent of resection of non-
enhancing gliomas have used various postoperative MRI
timings and sequences to determine residual tumour.
Examples include using T2 or FLAIR MRI within 48 h
postoperatively [25], MRI less than 48 h postoperatively
and FLAIR-weighted imaging with subtraction of areas that
were likely to contain oedema [3], unspecified postopera-
tive timing of T2- or FLAIR-weighted MRI when available
[26], unspecified timing of FLAIR-weighted MRI [4], T1-
weighted MRI at three to 6 months postoperatively [27],
unspecified postoperative timing of T2- and FLAIR-
weighted MRI [28] and T2-weighted MRI at five or six
weeks postoperatively [29]. In order to determine the
impact of residual tumour on the course of disease and to
be able to compare the extent of resection between patient
series, it seems reasonable to use standardised objective
criteria for measurements of residual tumour. Based on our
observations, we recommend avoiding measuring the extent
of resection on MRI immediately after resection. We also
recommend incorporating diffusion-weighted imaging into
the immediate postoperative MRI for distinction between
residual tumour and ischaemia in the reporting of results on
residual tumour after non-enhancing glioma resections.
Notwithstanding this limitation, early postoperative MRI
is clearly useful for a number of other purposes. First, as
several of these patients will be diagnosed with high-grade
glioma, baseline imaging for response evaluation of
adjuvant treatment is assured by early postoperative MRI.
Second, incidental tumour progression between resection
and late postoperative MRI can be detected only in
Fig. 4 An example of preoperative, early and late postoperative MRI
displaying T2-, FLAIR- and diffusion-weighted axial images and
volume contours. This 36-year old man with an oligoastrocytoma in
the left cingulate gyrus had preoperative T2 and FLAIR tumour
volumes of 101 and 94 cm
3, respectively, outlined in green, with faint
(2%) T1 gadolinium enhancement 3 weeks before resection. The
residual T2 and FLAIR volumes 2 days after surgery were 35 and
61 cm
3, respectively, outlined in red, with a diffusion restriction
volume of 37 cm
3. The residual T2 and FLAIR volumes 97 days after
resection measured 27 and 21 cm
3, respectively, outlined in yellow.
Note the involution of the hyperintensity at the lateral margin of the
resection cavity with restricted diffusion, interpreted as resection-
induced ischaemia, and the stable hyperintensity at the posterior
margin of the resection cavity, presumably genuine residual glioma
within the corticospinal tract
1532 Eur Radiol (2011) 21:1526–1534comparison with an early postoperative MRI. Third, new
gadolinium enhancement on late postoperative MRI can be
recognised as ischaemia-related luxury perfusion rather
than be misinterpreted as anaplastic transformation [30].
Fourth, immediate postoperative deficits can be placed in
the context of proximity of the resection cavity to eloquent
structures and resection-induced diffusion restriction of
these structures. Fifth, it is likely that more educational
benefit is obtained for the surgical team from early
postoperative MRI with feedback information on the
surgical decisions rather than from postoperative MRI
months after resection.
One limitation of this study is that the timing of the late
postoperative MRI was not standardised and serial late
postoperative measurements are lacking. Therefore, the
optimal timing for late postoperative MRI remains uncer-
tain. Another limitation is that for only a subset of patients
FLAIR-weighted imaging was available both early and late
postoperatively. This is due to the fact that the FLAIR and
DWI sequences were added to the routine imaging protocol
in the last year of patient inclusion. Despite this potential
lack of power, a systematic difference was detected
between early and late postoperative residual volumes
based on FLAIR-weighted imaging in 14 patients. A
further limitation is that some patients were adjuvantly
treated with radio- or chemotherapy protocolised by trial
participation, which could potentially interfere with late
residual tumour volumes. This would however result in an
underestimation of the observed postoperative reduction of
residual tumour volume.
As a consequence of the overestimation of residual
tumour on early MRI, we propose that quantitation of
extent of resection is preferably based on MRI months after
resection. The optimal timing of postoperative MRI for
standardized criteria is to be determined in future prospec-
tive studies. Furthermore, estimates of residual tumour
based on early MRI are to be carefully distinguished from
regions with resection-induced diffusion restriction to avoid
undue underestimation of surgical treatment effects.
In conclusion, our observation of a systematic and
substantial overestimation of residual non-enhancing volume
on MRI within 48 h of resection compared with months after
resectionindicatesthatearlypostoperativeMRIislessreliable
for volumetry of non-enhancing residual glioma. Diffusion-
weighted imaging to detect resection-induced ischaemia is
imperative in the interpretation of postresection tumour
volumes.
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